
|Articles|November 1, 2004
Wart treatment shows excellent safety, efficacy
New York - Topical 5-fluorouracil 5 percent cream (Efudex, Valeant) appears to be a low-risk, low-cost, rapidly effective and well-tolerated treatment for common warts in children, according to the results of a pilot study presented by Bari B. Cunningham, M.D., at the American Academy of Dermatology's Academy `04, here this summer.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















